The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer’s Disease Patients, Possible Biomarkers for Early Diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have demonstrated that neurotoxic astrocytes are induced by pro-inflammatory microglia through the secretion of factors including TNFα, IL-1α and C1q (10, 36)”
From A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation (2026) · cites this paper as [36]
In the citing paper
“In glaucoma, microglial activation is associated with morphological changes, increased phagocytosis, and the release of pro-inflammatory factors such as TNF-α, IL-1β, and IL-6, which contribute to RGC degeneration and tissue damage (29, 36, 40).”
From A human pluripotent stem cell triculture platform to elucidate microglial regulation of retinal ganglion cells in neuroinflammation (2026) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Liddelow, S. A., & Barres, B. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.006 · Cited by 2,336
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2018.05.003 · Cited by 1,474 · cited 1×
“Moreover, a specific microglia phenotype has been described in neurodegenerative diseases characterized by the downregulation of microglia homeostatic genes, the upregulation of specific degeneration associated markers (DAM), and sustained by the upregulation of TREM2 (Yeh et al., 2017; Deczkowska et al., 2018).”
BackgroundAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 1×
“Astrocytes activation can have a neuroprotective effect but it may trigger the release of pro-inflammatory species such as cytokines and chemokines (Stadelmann et al., 2002; Farina et al., 2007).”
BackgroundTREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220 · cited 1×
“However, microglia, astrocytes and immune signaling are not just secondary players in disease processes but actually contribute to synaptic and neuron loss and buildup of pathogenic proteins even at the earliest stages of disease (Hong et al., 2016; Shi et al., 2017; Sosna et al., 2018).”
BackgroundSheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
TREM2 — a key player in microglial biology and Alzheimer disease
Ulland, T. K., & Colonna, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0072-1 · Cited by 735 · cited 4×
“…the central nervous system (CNS) is widely recognized, as TREM2 mutations are linked to an increased risk of developing several neurodegenerative diseases (Ulland and Colonna, 2018), and TREM2 RNA has been found to be upregulated in the brain of patients and mouse models (Keren-Shaul et al., 2017).”
InfluentialLian, H., Yang, L., Cole, A., Sun, L., Chiang, A. C.-A., Fowler, S. W., Shim, D. J., Rodriguez-Rivera, J., Taglialatela, G., Jankowsky, J. L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.11.018 · Cited by 697
Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., Schwartz, M., & Farkas, D. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.020 · Cited by 672
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni, G. B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., Démonet, J.-F., Garibotto, V., Giannakopoulos, P., Gietl, A., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30159-x · Cited by 626
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
TREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440
Sosna, J., Philipp, S., Albay, R., Reyes-Ruiz, J. M., Baglietto-Vargas, D., LaFerla, F. M., & Glabe, C. G. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0244-x · Cited by 406 · cited 1×
“However, microglia, astrocytes and immune signaling are not just secondary players in disease processes but actually contribute to synaptic and neuron loss and buildup of pathogenic proteins even at the earliest stages of disease (Hong et al., 2016; Shi et al., 2017; Sosna et al., 2018).”
Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348 · cited 1×
“For this reason, we used post-mortem retinal slices from AD patients to investigate the presence of classical AD features and the expression of specific neuron-to-glia signaling proteins found both in the CSF of AD patients and in the brain of AD mouse models (Doens and Fernández, 2014).”
MethodThe identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247 · cited 1×
“TREM2 transcript has been shown to be over-expressed by microglia both in the brain of AD mouse models as well as human patients (Frank et al., 2008; Lue et al., 2015; Wang et al., 2015), suggesting that TREM2 upregulation could mirror with AD progression.”
BackgroundRowe, C. C., Bourgeat, P., Ellis, K. A., Brown, B., Lim, Y. Y., Mulligan, R., Jones, G., Maruff, P., Woodward, M., Price, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24040 · Cited by 222
Petersen, R. C., Wiste, H. J., Weigand, S. D., Rocca, W. A., Roberts, R. O., Mielke, M. M., Lowe, V. J., Knopman, D. S., Pankratz, V. S., Machulda, M. M., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3098 · Cited by 196
Lue, L., Schmitz, C. T., Serrano, G., Sue, L. I., Beach, T. G., & Walker, D. G. (2015) · Brain Pathology · doi:10.1111/bpa.12190 · Cited by 154
Bhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147 · cited 1×
“Indeed, while microglia TREM2 expression is important in triggering and sustaining the DAM phenotype in response to protein aggregates during disease progression (Song and Colonna, 2018; Ulland and Colonna, 2018), downregulation of TREM2 has been reported in human post-mortem retinal tissues of patients suffering from…”
BackgroundHoh Kam, J., Lenassi, E., & Jeffery, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013127 · Cited by 131 · cited 1×
“Similar results have been confirmed by other research groups (Hoh Kam et al., 2010; Alexandrov et al., 2011; Koronyo-Hamaoui et al., 2011; Koronyo et al., 2017), in addition a positive correlation between inclusion body and cortical amyloid burden has been observed (Snyder et al., 2016).”
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128
Research works printed but not linked: 41
- Ahmed, 2017, Co-localization of glia maturation factor with nlrp3 inflammasomeand autophagosome markers in human Alzheimer’s disease brain., J. Alzheimers. Dis., 60, 1143, 10.3233/JAD-170634 · DOI
- 2009, Alzheimer’s Disease International World Alzheimer Report.
- Bambo, 2015, “Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia., Acta Ophthalmol., 93, e507, 10.1111/aos.12635 · doi:10.1111/aos.12635
- Beach, 1989, Patterns of gliosis in Alzheimer’s disease and aging cerebrum., Glia, 2, 420, 10.1002/glia.440020605 · DOI · Paper page
- Cattoretti, 1993, Antigen unmasking on formalin−fixed, paraffin−embedded tissue sections., J. Pathol., 171, 83, 10.1002/path.1711710205 · DOI · Paper page
- Chakrova, 2016, Deconvolution methods for structured illumination microscopy., J. Opt. Soc. Am. A Opt. Image Sci. Vis., 33, B12, 10.1364/JOSAA.33.000B12 · DOI
- Chang, 2014, Alzheimer’s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers., Alzheimer’s Dement., 10, 251, 10.1016/j.jalz.2013.06.004 · DOI · Paper page
- Criscuolo, 2018, The retina as a window to early dysfunctions of Alzheimer’s disease following studies with a 5xFAD mouse model., Neurobiol. Aging., 67, 181, 10.1016/j.neurobiolaging.2018.03.017 · DOI
- den Haan, 2018, Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas., Acta Neuropathol. Commun., 6, 10.1186/s40478-018-0650-x · DOI · Paper page
- Duan, 2015, Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling., Neuron, 85, 1244, 10.1016/j.neuron.2015.02.017 · DOI · Paper page
- Elahi, 2017, A clinicopathological approach to the diagnosis of dementia., Nat. Rev. Neurol., 13, 457, 10.1038/nrneurol.2017.96 · DOI · Paper page
- Fahrenhold, 2018, MRC-CFAS. TREM2 expression in the human brain: a marker of monocyte recruitment?, Brain Pathol., 28, 595, 10.1111/bpa.12564 · DOI
- Gilbert, 2007, The isolation of nucleic acids from fixed, paraffin-embedded tissues–which methods are useful when?, PLoS One., 2, 10.1371/journal.pone.0000537 · DOI · Paper page
- Grimaldi, 2018, Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer’s disease in the 3xTg-AD mouse model., Cell Death Dis., 9, 10.1038/s41419-018-0740-5 · DOI · Paper page
- Hart, 2016, Ocular indicators of Alzheimer’s: exploring disease in the retina., Acta Neuropathol., 132, 767, 10.1007/s00401-016-1613-6 · DOI · Paper page
- Heintzmann, 2006, High-resolution image reconstruction in fluorescence microscopy with patterned excitation., Appl. Opt., 10, 5037, 10.1364/AO.45.005037 · DOI
- Henstridge, 2019, Beyond the neuron-cellular interactions early in Alzheimer disease pathogenesis., Nat. Rev. Neurosci., 20, 94, 10.1038/s41583-018-0113-1 · DOI · Paper page
- Ingaramo, 2014, Richardson-Lucy deconvolution as a general tool for combining images with complementary strengths., Chemphyschem, 15, 794, 10.1002/cphc.201300831 · DOI
- Iram, 2016, Astrocytes from old Alzheimer’s disease mice are impaired in Aβ uptake and in neuroprotection., Neurobiol. Dis., 96, 84, 10.1016/j.nbd.2016.08.001 · DOI
- Javaid, 2016, Visual and ocular manifestations of Alzheimer’s disease and their use as biomarkers for diagnosis and progression., Front. Neurol., 19, 10.3389/fneur.2016.00055 · DOI · Paper page
- Ju, 2000, Ganglion cells of the rat retina show osteopontin-like immunoreactivity., Brain Res., 852, 217, 10.1016/s0006-8993(99)02140-x · DOI
- Kavcic, 2011, Distinct visual motion processing impairments in aging and Alzheimer’s disease., Vision Res., 51, 386, 10.1016/j.visres.2010.12.004 · DOI
- Koronyo, 2017, Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease., JCI Insight, 2, 10.1172/jci.insight.93621 · DOI · Paper page
- Lee, 2014, Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report., J. Med. Case Rep., 8, 10.1186/1752-1947-8-155 · doi:10.1186/1752-1947-8-155
- Liu, 2014, Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells., Exp. Eye Res., 127, 49, 10.1016/j.exer.2014.07.003 · DOI
- Löffler, 1995, Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina., Invest. Ophthalmol. Vis. Sci., 36, 24
- Louneva, 2008, Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer’s disease, Am. J. Pathol., 173, 1488, 10.2353/ajpath.2008.080434 · DOI · Paper page
- Lynn, 2017, The complexities underlying age-related macular degeneration: could amyloid beta play an important role?, Neural Regen. Res., 12, 538, 10.4103/1673-5374.205083 · DOI
- Paquet, 2007, Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer’s disease., Neurosci. Lett., 420, 97, 10.1016/j.neulet.2007.02.090 · DOI · Paper page
- Raj, 2010, Detection of individual endogenous RNA transcripts in situ using multiple singly labeled probes., Methods Enzymol., 472, 365, 10.1016/S0076-6879(10)72004-8 · DOI · Paper page
- Rosenzweig, 2019, PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model., Nat. Commun., 10, 10.1038/s41467-019-08352-5 · DOI · Paper page
- Sekar, 2016, Schizophrenia risk from complex variation of complement component 4., Nature, 530, 177, 10.1038/nature16549 · DOI · Paper page
- Sernagor, 2001, Development of retinal ganglion cell structure and function., Prog. Retin. Eye Res., 20, 139, 10.1016/s1350-9462(00)00024-0 · DOI · Paper page
- Snyder, 2016, Nonvascular retinal imaging markers of preclinical Alzheime”s disease., Alzheimers Dement., 1, 169, 10.1016/j.dadm.2016.09.001 · DOI
- Stadelmann, 2002, BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?, Brain., 125, 75, 10.1093/brain/awf015 · DOI · Paper page
- Stevens, 2007, The classical complement cascade mediates CNS synapse elimination., Cell., 14, 1164, 10.1016/j.cell.2007.10.036 · DOI · Paper page
- Ströhl, 2015, A joint richardson-lucy deconvolution algorithm for the reconstruction of multifocal structured illumination microscopy data., Methods Appl. Fluoresc., 3, 10.1088/2050-6120/3/1/014002 · DOI
- Thomson, 2005, A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography., Alzheimers Dement., 1, 136, 10.1016/j.dadm.2015.03.001 · DOI · Paper page
- Wang, 2015, TREM2 lipid sensing sustains the microglial response in an Alzheimer’s disease model., Cell., 160, 1061, 10.1016/j.cell.2015.01.049 · DOI · Paper page
- Wung, 2007, Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neu- ons of the Alzheimer’s disease brain., Curr. Alzheimer Res., 4, 67, 10.2174/156720507779939869 · DOI
- Zhao, 2015, Beta-Amyloid precursor protein (βAPP) processing in Alzheimer’s Disease(AD) and age-related macular degeneration (AMD)., Mol. Neurobiol., 52, 533, 10.1007/s12035-014-8886-3 · DOI
Cited by
Roles of neuropathology-associated reactive astrocytes: a systematic review
Lawrence, J. M., Schardien, K., Wigdahl, B., & Nonnemacher, M. R. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01526-9 · Cited by 433
Microglial NLRP3 inflammasome activates neurotoxic astrocytes in depression-like mice
Li, S., Fang, Y., Zhang, Y., Song, M., Zhang, X., Ding, X., Yao, H., Chen, M., Sun, Y., Ding, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111532 · Cited by 225
Zhang, H.-Y., Wang, Y., He, Y., Wang, T., Huang, X.-H., Zhao, C.-M., Zhang, L., Li, S.-W., Wang, C., Qu, Y.-N., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01871-9 · Cited by 161
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149
What are activated and reactive glia and what is their role in neurodegeneration?
Bennett, M. L., & Viaene, A. N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105172 · Cited by 77
Metadata
- Authors
- Grimaldi, A., Pediconi, N., Oieni, F., Pizzarelli, R., Rosito, M., Giubettini, M., Santini, T., Limatola, C., Ruocco, G., Ragozzino, D., & Di Angelantonio, S.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-09-04
- Volume
- 13
- ISSN
- 1662-453X
- Cited by
- 157
- References
- 29
- Funders
- Regione Lazio
- Horizon 2020 Framework Programme
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.